Pfizer v. Softgel: The Errors of Comity
On January 28, the Madras High Court passed an order related to an ongoing patent dispute in the United States. The dispute concerned Cipla’s and Zenara (Hikma)’s ANDA applications seeking approval to market their generic versions of Vyndamax (tafamidis), a drug used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), in the US. Pfizer, the petitioner, argued before the US District Court, Delaware that the ANDA applications infringed its US patent. To further prove its allegation Pfizer requested the Court to issue […]
Pfizer v. Softgel: The Errors of Comity Read More »










